Salmonellae are pathogenic bacteria that induce immunosuppression by mechanisms that remain largely unknown. Previously, we showed that a putative type II L-asparaginase produced by Salmonella Typhimurium inhibits T cell responses and mediates virulence in a murine model of infection. Here, we report that this putative L-asparaginase exhibits L-asparagine hydrolase activity required for Salmonella Typhimurium to inhibit T cells. We show that L-asparagine is a nutrient important for T cell activation and that L-asparagine deprivation, such as that mediated by the Salmonella Typhimurium L-asparaginase, causes suppression of activation-induced mammalian target of rapamycin signaling, autophagy, Myc expression, and L-lactate secretion. We also show that L-asparagine deprivation mediated by the Salmonella Typhimurium L-asparaginase causes suppression of cellular processes and pathways involved in protein synthesis, metabolism, and immune response. Our results advance knowledge of a mechanism used by Salmonella Typhimurium to inhibit T cell responses and mediate virulence, and provide new insights into the prerequisites of T cell activation. We propose a model in which L-asparagine deprivation inhibits T cell exit from quiescence by causing suppression of activation-induced metabolic reprogramming.
Introduction
Bacterial pathogens must avoid clearance by the immune system to establish infection, yet many mechanisms of bacterial immune subversion remain undefined. A number of bacterial pathogens subvert pathways of the innate immune system, but how bacterial pathogens overcome pathways of the adaptive immune system is not well understood [1] [2] [3] . T cells are a key component of the adaptive immune system and are required for protective immunity against many bacterial pathogens [4] [5] [6] [7] [8] [9] [10] . Recent studies have shown that a number of bacterial pathogens, including Salmonella Typhimurium, can directly inhibit T cells [11] [12] [13] [14] [15] [16] [17] , providing insight into the types of strategies used by pathogenic bacteria to overcome pathways of the adaptive immune system.
Salmonellae are a leading cause of morbidity and mortality in humans worldwide [18] [19] [20] [21] . Infections with Salmonellae range in severity, from self-limiting gastroenteritis to typhoid fever, and can lead to chronic carriage. Nontyphoidal Salmonellae, such as Salmonella Typhimurium, are a leading cause of inflammatory enterocolitis and death as a result of foodborne illness and a significant cause of invasive bacteremia in immunocompromised hosts. Typhoidal Salmonellae, such as Salmonella enterica serovar Typhi, cause systemic infections characterized by bacterial penetration of the intestinal barrier and extraintestinal dissemination to the liver and spleen, where the microorganisms survive and replicate in professional phagocytes. Septic shock and death can occur if systemic infections are left untreated [20, 22] .
Much of what is known about the pathogenesis of and host response to Salmonellae comes from experimental infection of mice with Salmonella Typhimurium, which has served as a useful model for the human disease caused by Salmonella enterica serovar Typhi [4, 6, 23] . In susceptible strains of mice, Salmonella Typhimurium induces acute immunosuppression and delays onset of protective immune responses [2, 4, 6, 24, 25] . Immunity that eventually develops against Salmonella Typhimurium requires both humoral and cell-mediated immune responses. T cells, particularly IFN-g-producing CD4 + T cells, play a critical role in clearance of Salmonella Typhimurium. However, T cell responses to Salmonella Typhimurium are dampened during infection by mechanisms that remain poorly understood [2, 4, 6] .
Recently, we showed that a putative L-Asnase II protein produced by Salmonella Typhimurium inhibits T cell responses and mediates virulence [13] . Specifically, we showed that L-Asnase II produced by Salmonella Typhimurium is necessary and sufficient to cause suppression of T cell blastogenesis, cytokine production, and proliferation and downmodulation of TCR expression [13] . However, the mechanism by which Salmonella Typhimurium L-Asnase II inhibits T cell activation has remained elusive.
Here, we found that L-Asnase II of Salmonella Typhimurium exhibits Asn hydrolase activity required for Salmonella Typhimuriuminduced inhibition of T cells. Moreover, we found that Asn is a nutrient important for T cell activation and that Asn deprivation, such as that mediated by L-Asnase II of Salmonella Typhimurium, causes suppression of activation-induced T cell metabolic reprogramming. These findings advance knowledge of a mechanism used by Salmonella Typhimurium to establish infection and avoid clearance by the immune system, and provide new insights into the prerequisites of T cell activation.
MATERIALS AND METHODS

Ethics statement
All procedures that use mice were approved by the Institutional Animal Care and Use Committee at Stony Brook University and were conducted in accordance with the recommendations outlined in the Guide for the Care and Use of Laboratory Animals of the NIH. All procedures that use mice were designed to use the fewest number of mice possible but still achieve meaningful results. Euthanasia of mice was performed by inhalation of carbon dioxide, a method consistent with the recommendations of the Panel on Euthanasia of the American Veterinary Medical Association.
Bacterial strains and culture conditions
Salmonella Typhimurium strain 14028 (American Type Culture Collection, Manassas, VA, USA) was used as the WT strain. Salmonella Typhimurium, lacking the L-Asnase II gene STM3106 (DSTM3106 Salmonella Typhimurium), DSTM3106 Salmonella Typhimurium complemented with a plasmid encoding STM3106 (pBAD-STM3106), and Escherichia coli strain LMG194 (Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA) transformed with a plasmid encoding STM3106 and an appended His tag (pBAD-STM3106His), have been published [13] . The generation of bacterial strains expressing enzymatically inactive L-Asnase II is described below. With the use of standard microbiological techniques, bacteria were grown aerobically at 37°C in LuriaBertani broth or on Luria-Bertani agar, except where noted. Chloramphenicol (30 mg/ml) and L-arabinose [0.1% (w/v)] were added to the culture medium to maintain plasmids in vivo and induce expression of plasmid-encoded LAsnase II, respectively.
Site-directed mutagenesis of STM3106
Site-directed mutagenesis was used to introduce a site-specific mutation into STM3106, resulting in an Ala substitution for Thr at position 89. The mutagenesis was performed on plasmids pBAD-STM3106 and pBAD-STM3106His by use of the QuickChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA) and primers 59-GGTTTCGTGATCACCCACGGTGCGGA-TACGATGGAAGAGACCGC-39 and 59-GCGGTCTCTTCCATCGTATCCGC-ACCGTGGGTGATCACGAAACC-39 or 59-GCTAGCGAAGAGATATACCA-TGGAGTTTTTCAGGAAAACGGC-39 and 59-TCTAGATTATTAGT-GGTGGTGGTGGTGGTGATACTGATTGAACATCGTCTGG-39, respectively. The resulting constructs, pBAD-STM3106T89A and pBADSTM3106HisT89A, were verified by DNA sequencing and introduced into DSTM3106 Salmonella Typhimurium or E. coli strain LMG194 by electroporation. Transformants were selected by use of Luria-Bertani agar, supplemented with chloramphenicol (30 mg/ml). Isolated single colonies were picked, and the presence of the plasmids was confirmed. The resulting strains grew normally and following induction with 0.1% (w/v) L-arabinose, expressed normal levels of plasmid-encoded L-Asnase II (data not shown).
Purification of L-Asnase II
Nickel-affinity chromatography was used to purify His-tagged L-Asnase II of Salmonella Typhimurium from E. coli strain LMG194 carrying plasmid pBADSTM3106His or pBAD-STM3106HisT89A, as described previously [13] .
L-Asnase II, used to perform steady-state kinetic assays, was purified essentially as described previously [13] , with the following modification: His-tagged L-Asnase II was purified from periplasmic extracts instead of culture supernatants to increase yield. To generate periplasmic extracts, bacterial pellets were suspended in buffer containing 200 mM Tris (pH = 8), 500 mM sucrose, and 0.5 mM EDTA. After 30 min of incubation at 4°C, samples were diluted 1:1 by use of ice-cold buffer containing 2 mM MgCl 2 . After overnight incubation at 4°C, samples were subjected to centrifugation, and supernatants were harvested and diluted 1:1 by use of buffer containing 20 mM Tris (pH = 8), 500 mM NaCl, and 20 mM imidazole. The resulting periplasmic extracts containing His-tagged L-Asnase II were subjected to nickel affinity chromatography, as described above. L-Asnase II, purified by use of this approach, was not endotoxin free and therefore, was used only to perform steady-state kinetic assays.
Kinetic analysis of coupled enzyme assay
Steady-state kinetic assays were performed at 25°C in 2 mM sodium phosphate buffer containing 5 nM-purified WT or mutant L-Asnase II, 1 mM EDTA, 10 mM a-ketogluterate, 250 mM NADPH, and 0.224 mg/ml glutamate dehydrogenase (Sigma-Aldrich, St. Louis, MO, USA). Reactions were initiated by the addition of Asn with concentrations ranging from 4.25 to 60 mM. The concentration of glutamate dehydrogenase ensured that the coupling step was not rate limiting, such that a 2-fold increase in L-Asnase II resulted in a corresponding 2-fold increase in rate. The enzyme activity was measured by monitoring the change in absorbance at 340 nm (e = 6,300 M ) by use of a Cary 100 Bio UV-Vis spectrophotometer (Varian/Agilent Technologies). All samples were run in duplicate. Initial velocities were determined by use of KaleidaGraph 4.1.3 (Synergy Software, Reading, PA, USA), and kinetic parameters were calculated by fitting the data to the Michaelis-Menten equation [26, 27] . In T cell assays aimed at measuring the effect of L-Asnase II produced by Salmonella Typhimurium on TCR-b surface expression, blastogenesis and IL-2 secretion-enriched populations of T cells suspended in medium supplemented with anti-CD28 mAb-were seeded into tissue-culture plates coated with anti-CD3e mAb, as described above. The T cells were then cultured in the absence or presence of WT Salmonella Typhimurium, DSTM3106 Salmonella Typhimurium, DSTM3106 Salmonella Typhimurium carrying plasmid pBAD-STM3106, or DSTM3106 Salmonella Typhimurium carrying plasmid pBAD-STM3106T89A at a multiplicity of infection of ;60. L-Arabinose was added to the cultures at a final concentration of 0.1% (w/v) to induce expression of His-tagged L-Asnase II by L-arabinose-pretreated bacteria. After 2 h of incubation at 37°C in 5% CO 2 , the T cells were pelleted by centrifugation and resuspended in medium, supplemented with 50 mg/ml gentamicin and 2% penicillin and streptomycin to kill all remaining bacteria. After an additional 20 h of incubation at 37°C in 5% CO 2 , culture supernatants were collected, and IL-2 concentrations were determined by use of ELISA. Additionally, the T cells were harvested, stained, and analyzed by use of flow cytometry.
In T cell assays aimed at measuring the effect of Asn deprivation on TCR-b surface expression, blastogenesis, IL-2 secretion, and viability, enriched populations of T cells were suspended in medium lacking Asn [RPMI-1640 medium lacking Asn, Lys, and Arg (Caisson Laboratories, North Logan, UT, USA), supplemented with 0.218998 mM (47.98467 mg/l) Lys (Cambridge Isotope Laboratories, Tewksbury, MA, USA), 1.150242 mM (242.31 mg/l) Arg (Cambridge Isotope Laboratories), 10% dialyzed FBS (Caisson Laboratories), 0.2 M Gln, 0.1 M HEPES, 50 mM 2-ME, and 1% penicillin and streptomycin], supplemented with anti-CD28 mAb, and seeded into tissue-culture plates coated with anti-CD3e mAb, as described above. Where indicated, Asn (SigmaAldrich) was added to the medium at a final concentration of 0.378472 mM (50.0037 mg/l) to make complete RP-10 medium. After 20 h of incubation at 37°C in 5% CO 2 , culture supernatants were collected, and IL-2 concentrations were determined by use of ELISA. Additionally, the T cells were harvested, stained, and analyzed by use of flow cytometry.
In T cell assays aimed at measuring the effect of L-Asnase II on the levels of S6, phosphorylated S6, LC3 and Myc expression, and L-lactate secretion, enriched populations of T cells, suspended in medium supplemented with 1 mg/ml anti-CD28 mAb, were seeded at 1.0 3 10 6 cells/well into 24-well tissue-culture plates coated with 5 mg/ml anti-CD3e mAb. The T cells were then left untreated or treated with 50 ng/ml purified WT L-Asnase II or mutant L-Asnase II. Where indicated, leupeptin (Thermo Fisher Scientific), a protease inhibitor, and ammonium chloride (Acros Organics, Thermo Fisher Scientific), a compound that, by causing the pH of lysosomes to increase, inhibits the activity of acidic pH-dependent lysosomal proteases and perturbs phagosome-lysosome fusion, were added to the cultures 3 h before harvest at final concentrations of 100 mM and 20 mM, respectively, to prevent intralysosomal degradation of LC3-II. After 12 h of incubation at 37°C in 5% CO 2 , culture supernatants were collected, and L-lactate concentrations were determined by use of an L-lactate assay. Additionally, the T cells were harvested and lysed by use of radioimmunoprecipitation assay buffer (SigmaAldrich), supplemented with 13 cocktails of protease and phosphatase inhibitors (Roche Applied Science, Indianapolis, IN, USA). The protein concentrations of the resulting whole-cell lysates were determined by use of the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, USA), after which up to 9 mg of each sample was subjected to PAGE and Western blot analysis. Parallel T cell assays, aimed at measuring the effect of Asn deprivation on levels of S6, phosphorylated S6, LC3 and Myc expression, and L-lactate secretion, were performed, essentially as described above. In T cell assays aimed at measuring incorporation of exogenous Asn, enriched populations of T cells were suspended in medium containing heavy, [ 13 
IL-2 ELISA
IL-2 concentrations in collected T cell supernatants were determined by use of the Mouse IL-2 ELISA MAX Deluxe Kit (BioLegend).
L-Lactate assay
L-Lactate concentrations in collected T cell supernatants were determined by use of the EnzyChrom L-Lactate Assay Kit (BioAssay Systems, Hayward, CA, USA).
PAGE and Western blot analysis
Aliquots of whole-cell lysates were mixed with SDS-PAGE sample buffer (13 final), boiled for 15 min, centrifuged briefly to pellet debris, and loaded onto a 12% Tris-Gly polyacrylamide gel (Bio-Rad 
Multidimensional chromatography and tandem MS
Peptide mixtures, generated in T cell assays aimed at measuring incorporation of exogenous Asn (see above), were pressure loaded onto a 250 mm inner diameter-fused silica capillary, packed first with 3 cm of 5 mm strong cation exchange material (PartiSphere SCX; Whatman, GE Healthcare), followed by 3 cm of 10 mm C18 reverse-phase particles (Aqua, Phenomenex, Torrance, CA, USA). Loaded and washed microcapillaries were connected via a 2 mm filtered union (UpChurch Scientific, IDEX Health & Science, Oak Harbor, WA, USA) to a 100 mm inner-diameter column, which had been pulled to a 5 mm innerdiameter tip by use of a P-2000 CO 2 laser puller (Sutter Instruments, Novato, CA, USA), then packed with 13 cm of 3 mm C18 reverse-phase particles, and equilibrated in buffer containing 5% acetonitrile, 0.1% formic acid (buffer A). This split column was then installed in-line with a NanoLC HPLC pump (Eskigent Technologies, SCIEX, Framingham, MA, USA). The flow rate of channel 2 was set at 300 nl/min for the organic gradient. The flow rate of channel 1 was set to 0.5 ml/min for the salt pulse. Fully automated, 11-step chromatography runs were carried out. Three different elution buffers were used: 5% acetonitrile, 0.1% formic acid (buffer A); 98% acetonitrile, 0.1% formic acid (buffer B); and 0.5 M ammonium acetate, 5% acetonitrile, 0.1% formic acid (buffer C). In such sequences of chromatographic events, peptides are sequentially eluted from the PartiSphere SCX resin to the reverse-phase resin by increasing salt steps (increase in buffer C concentration), followed by organic gradients (increase in buffer B concentration). The last chromatography step involved a high salt wash with 100% buffer C, followed by acetonitrile gradient. The application of a 2.5 kV distal voltage electrosprayed the eluting peptides directly into an LTQ-Orbitrap XL mass spectrometer, equipped with a nano-liquid chromatography electrospray ionization source (Thermo Finnigan, Thermo Fisher Scientific). Full MS spectra were recorded on the peptides over a 400-to-2000 m/z range by Orbitrap, followed by 5 tandem MS events, sequentially generated by LTQ in a data-dependent manner on the first, second, third, and fourth most intense ions selected from the full MS spectrum (at 35% collision energy). Mass spectrometer scan functions and HPLC solvent gradients were controlled by the Xcalibur data system (Thermo Finnigan, Thermo Fisher Scientific).
Database search and interpretation of tandem MS datasets
Tandem mass spectra were searched against a concatenated target-decoy database containing the forward and reverse sequences of the target database by use of the Andromeda search engine. The target sequence was downloaded from a mouse UniProt database, released on March 6, 2013 [28] , and 124 common contaminant proteins. In Andromeda, we specified [ 13 C] 4 -Asn and
15 N 4 -L-arginine as the labels for the database search. The quantitative proteomics software package MaxQuant (Max Planck Institute of Biochemistry, Martinsried, Germany) was used to report a list of identified proteins and ratios of heavy and light Asn and Arg. The peptide mass search tolerance was set to 10 ppm. No differential modifications were considered. Tryptic status was imposed on the database search. The discriminant score was set such that a false-positive rate of 1% was determined based on the number of accepted decoy database peptides.
Statistical analysis
Statistical analysis was performed by use of Prism 5.0b (GraphPad Software, La Jolla, CA, USA). Data were analyzed by use of a 2-tailed, paired Student's t test or repeated-measures one-way ANOVA with Tukey's or Dunnett's multiple comparisons post-test; P , 0.05 was considered to be statistically significant (see figure legends for detailed significance levels).
RESULTS
L-Asnase II of Salmonella Typhimurium exhibits Asn hydrolase activity
We previously showed that the STM3106 gene is required for Salmonella Typhimurium to inhibit T cell responses and mediate virulence [13] . This gene encodes a putative L-Asnase that is 93% identical to L-Asnase II of E. coli at the primary amino acid level (Supplemental Fig. 1A ). We used a coupled enzyme assay to determine the ability of this putative L-Asnase to hydrolyze Asn (Supplemental Fig. 1B ). The assay is based on the principle that Asn hydrolysis results in the production of ammonia, which, in the presence of NADPH and glutamate dehydrogenase, reacts with a-ketogluterate to form L-glutamate and NADP + [29, 30] . The amount of NADP + formed is stoichiometric, with the amount of ammonia generated as a result of Asn hydrolysis. Thus, NADPH oxidation provides a functional readout for Asn hydrolase activity. We performed steady-state kinetic assays to measure L-Asnase II-catalyzed NADPH oxidation and plotted the initial velocity of the reaction as a function of Asn substrate concentration (Fig. 1) .
The calculated values of the kinetic parameters K m , k cat , and k cat /K m were 11.8 6 1.8 mM, 7587 6 190 min Asn hydrolase activity is required for L-Asnase II of Salmonella Typhimurium to cause inhibition of T cell activation
To determine whether Asn hydrolase activity is required for L-Asnase II of Salmonella Typhimurium to cause T cell inhibition, we substituted Ala for Thr at position 89, a conserved amino acid residue important for enzymatic activity of L-Asnase II of E. coli [34] . With the use of the coupled enzyme assay, we detected NADPH oxidation with purified WT L-Asnase II but not mutant L-Asnase II ( Fig. 2A) . These results indicate that the Ala substitution for Thr at position 89 (T89A) rendered L-Asnase II of Salmonella Typhimurium enzymatically inactive and that Thr at position 89 was identified correctly as a catalytic residue. We next treated T cells with purified WT L-Asnase II or enzymatically inactive L-Asnase II. T cells left untreated were used as a control. After 20 h of incubation in the presence of anti-CD3e and anti-CD28 mAb, T cells treated with WT L-Asnase II expressed significantly less surface TCR-b than T cells treated with enzymatically inactive L-Asnase II or T cells left untreated (Fig. 2B) . Furthermore, T cells treated with enzymatically inactive L-Asnase II expressed levels of surface TCR-b that were comparable to the levels expressed by T cells left untreated (Fig. 2B) . Similar results were obtained when we evaluated the ability of the T cells to blast (Fig. 2C) or secrete IL-2 ( Fig. 2D) , or when we used untouched T cells (Supplemental Fig. 2A and B). Consistent with these results, we found that Salmonella Typhimurium expressing enzymatically inactive L-Asnase II were unable to cause down-modulation of TCR-b surface expression (Fig. 2E) and suppression of T cell blastogenesis (Fig. 2F ) and IL-2 secretion (Fig. 2G ) when compared with Salmonella Typhimurium expressing WT L-Asnase II. Collectively, these results indicate that Asn hydrolase activity is required for L-Asnase II of Salmonella Typhimurium to cause inhibition of T cell activation.
Exogenous Asn is a nutrient important for T cell activation
An immediate implication of our results indicating that the Asn hydrolase activity of L-Asnase II is required for Salmonella Typhimurium to inhibit T cells (Fig. 2) is that exogenous Asn is a nutrient important for T cell function. To define the effect of Asn deprivation on T cell activation, we cultured T cells in medium lacking Asn. T cells cultured in medium containing Asn were used as a control. After 20 h of incubation in the presence of anti-CD3e and anti-CD28 mAb, T cells cultured in medium lacking Asn expressed significantly less surface TCR-b than T cells cultured in medium containing Asn (Fig. 3A) . Moreover, T cells cultured in medium lacking Asn expressed levels of surface TCR-b that were comparable with the levels expressed by T cells cultured with WT Salmonella Typhimurium (Fig. 3A) . The lack of exogenous Asn similarly caused suppression of T cell blastogenesis (Fig. 3B ) and IL-2 secretion (Fig. 3C ) but did not adversely affect T cell viability ( Fig. 3D) . Collectively, these results indicate that exogenous Asn is a nutrient important for T cell activation.
Asn deprivation causes inhibition of T cell activation characterized by the suppression of mTOR signaling, autophagy, Myc expression, and L-lactate secretion Recent studies have linked amino acid sensing to mTOR, a Ser/Thr protein kinase that plays a key role in integrating and transmitting environmental signals to direct cellular processes, such as autophagy and metabolism [35, 36] . Active mTOR signaling can be measured by monitoring the increase in the phosphorylation status of S6, a main downstream target of mTOR signaling [37, 38] . To define the effect of Asn deprivation on mTOR signaling, we monitored the phosphorylation status of S6 expressed by anti-CD3e/CD28-stimulated T cells cultured in medium lacking Asn. Naïve T cells and anti-CD3e/CD28-stimulated T cells cultured in medium containing Asn were used as controls. Interestingly, naïve T cells exhibited low levels of phosphorylated S6 over total S6 that increased considerably following TCR engagement ( Fig. 4A and Supplemental Fig. 3A) . Furthermore, stimulated T cells cultured in medium lacking Asn exhibited levels of phosphorylated S6 over total S6 that were substantially lower than the levels exhibited by stimulated T cells cultured in medium containing Asn (Fig. 4A and Supplemental  Fig. 3A) . Similar results were obtained when we monitored the phosphorylation status of S6, expressed by stimulated T cells cultured in medium treated with WT L-Asnase II or enzymatically inactive L-Asnase II (Fig. 4B and Supplemental Fig. 3B ). Thus, Asn deprivation causes inhibition of T cell activation characterized by the suppression of mTOR signaling.
A potential functional consequence of reduced mTOR signaling is induction of autophagy, a fundamental catabolic recycling process that has been implicated in T cell activation and metabolism [39] [40] [41] [42] . Autophagy involves the sequestration of cytosolic constituents into autophagosomes, which fuse with lysosomes to promote the degradation of cargo [43, 44] . During autophagy, the cytoplasmic form of LC3-I is processed and modified into a lipidated form (LC3-II) that is recruited to autophagosomal membranes [45] . LC3-II has been a reliable marker for monitoring autophagy [46] . To define the effect of Asn deprivation on autophagy, we measured LC3-II levels expressed by anti-CD3e/CD28-stimulated T cells treated with WT L-Asnase II or enzymatically inactive L-Asnase II. Naïve T cells and anti-CD3e/CD28-stimulated T cells left untreated were used as controls. Where indicated, leupeptin, a protease inhibitor, and ammonium chloride, a compound that, by causing the pH of lysosomes to increase, inhibits the activity of acidic pH-dependent lysosomal proteases and perturbs phagosome-lysosome fusion, were added to the cultures to prevent intralysosomal degradation of LC3-II and assess autophagic flux. Consistent with published evidence [40, 41] , naïve T cells exhibited a basal level of LC3-II expression and turnover that increased considerably following TCR engagement ( Fig. 4C and Supplemental Fig. 3C ). Surprisingly, stimulated T cells treated with WT L-Asnase II exhibited levels of LC3-II that were substantially lower than the levels exhibited by stimulated T cells left untreated and similar to the levels exhibited by naïve T cells (Fig. 4C and Supplemental  Fig. 3C ). Furthermore, stimulated T cells treated with enzymatically inactive L-Asnase II exhibited levels of LC3-II that were comparable to the levels exhibited by stimulated T cells left untreated ( Fig. 4C and Supplemental Fig. 3C ). Similar results were obtained when we assessed autophagic flux in anti-CD3e/ CD28-stimulated T cells cultured in medium lacking Asn (Fig. 4D and Supplemental Fig. 3D ). Thus, Asn deprivation causes T cell inhibition characterized by the suppression of activation-induced autophagy, which may be an mTOR-independent process important for T cell activation.
Another potential, functional consequence of reduced mTOR signaling is suppression of metabolic reprogramming [47, 48] . Naïve T cells primarily use mitochondria-dependent catabolic pathways to meet metabolic needs but up-regulate aerobic glycolysis and glutaminolysis following TCR engagement to meet increased metabolic demands [47, 48] . This metabolic shift, which leads to an increase in L-lactate secretion, is required for T cell activation [49] and has been linked to Myc, a transcription factor that positively controls activation-induced T cell metabolic reprogramming [50] . To define the effect of Asn deprivation on activation-induced T cell metabolic reprogramming, we measured Myc levels expressed by anti-CD3e/CD28-stimulated T cells treated with WT L-Asnase II or enzymatically inactive L-Asnase II. Naïve T cells and anti-CD3e/CD28-stimulated T cells left untreated were used as controls. Consistent with published evidence [50] , naïve T cells expressed low levels of Myc that increased considerably following TCR engagement (Fig. 4E and Supplemental Fig. 3E ). Interestingly, stimulated T cells treated with WT L-Asnase II expressed levels of Myc that were substantially lower than the levels expressed by stimulated T cells left untreated and similar to the levels expressed by naïve T cells (Fig. 4E and Supplemental Fig. 3E) . Furthermore, stimulated T cells treated with enzymatically inactive L-Asnase II expressed levels of Myc that were comparable with the levels expressed by stimulated T cells left untreated ( Fig. 4E and Supplemental  Fig. 3E ). Similar results were obtained when we measured Myc levels expressed by anti-CD3e/CD28-stimulated T cells cultured in medium lacking Asn (Fig. 4F and Supplemental Fig. 3F ). Consistent with these results, we detected reduced levels of L-lactate in supernatants harvested from anti-CD3e/CD28-stimulated T cells treated with WT L-Asnase II (Fig. 4G) or cultured in medium lacking Asn (Fig. 4H) . Thus, Asn deprivation causes inhibition of T cell activation characterized by the suppression of Myc expression and L-lactate secretion. Collectively, the results described in this section are evidence that Asn deprivation, such as that mediated by L-Asnase II of Salmonella Typhimurium, causes suppression of activation-induced T cell metabolic reprogramming.
Asn deprivation causes inhibition of T cell activation through suppression of cellular processes and pathways involved in protein synthesis, metabolism, and immune response
Our results, combined with recent evidence that has linked active mTOR signaling to global protein synthesis [51] , suggest that naïve T cells may need exogenous Asn to synthesize new proteins required for activation. We used a MS-based approach to test this hypothesis and study the incorporation of exogenous Asn into proteins newly synthesized by naïve T cells stimulated with antiCD3e and anti-CD28 mAb. The approach relies on the incorporation of stable, isotope-labeled (heavy) amino acids into newly synthesized proteins as they are turned over, and a shift in the isotopic distributions of peptides can be resolved by use of a high-resolution mass spectrometer [52] . We performed the metabolic labeling experiments by culturing the T cells in medium containing [ 13 C] 4 -Asn and [ 13 C] 6 15 N 4 -Arg. Incorporation of heavy Arg, while the T cells were also being labeled with heavy Asn, was used to measure global protein turnover. After 24 h of labeling, we found proteome-wide incorporation of heavy Asn and Arg by the detection of heavy amino acid-containing peptides from total cell lysates (data not shown), indicating that stimulated T cells can incorporate these exogenous amino acids into newly synthesized proteins.
We next treated stimulated T cells cultured in medium containing heavy Asn and Arg with purified WT L-Asnase II or enzymatically inactive L-Asnase II. Stimulated T cells left untreated were used as a control. After 24 h of metabolic labeling, T cells treated with WT L-Asnase II showed substantially less incorporation of heavy Asn and Arg than T cells left untreated and T cells treated with enzymatically inactive L-Asnase II (Fig. 5A  and B) . Furthermore, T cells treated with enzymatically inactive L-Asnase II showed levels of heavy Asn and Arg incorporation that were comparable to the levels incorporated by T cells left untreated ( Fig. 5A and B) . These results indicate that Asn deprivation, mediated by L-Asnase II of Salmonella Typhimurium, causes suppression of de novo protein synthesis. Upon further analysis of proteins that were metabolically labeled and differentially affected by the presence of WT L-Asnase II or enzymatically inactive L-Asnase II, we found that they were significantly enriched for those that participate in cellular processes, such as translation initiation, metabolism, and immune response (Supplemental Fig.  4) . These results are consistent with our finding that Asn is a nutrient important for T cell activation (Fig. 3) and suggest that future studies of these proteins will likely advance knowledge of their role in T cell function.
DISCUSSION
We report that Asn deprivation, such as that mediated by L-Asnase II of Salmonella Typhimurium, causes suppression of activation-induced T cell metabolic reprogramming. Specifically, we found that L-Asnase II of Salmonella Typhimurium exhibits Asn hydrolase activity required for Salmonella Typhimuriuminduced inhibition of T cells (Figs. 1 and 2 and Supplemental Figs. 1  and 2 ). Furthermore, we found that exogenous Asn is a nutrient important for T cell activation and that Asn deprivation, such as that mediated by L-Asnase II of Salmonella Typhimurium, causes inhibition of T cell activation characterized by the suppression of mTOR signaling, autophagy, Myc expression, and L-lactate secretion (Figs. 3  and 4 and Supplemental Fig. 3 ). We also found that Asn deprivation mediated by L-Asnase II of Salmonella Typhimurium causes suppression of cellular processes and pathways involved in translation, metabolism, and immune response ( Fig. 5 and Supplemental Fig. 4) . These results advance knowledge of a mechanism used by Salmonella Typhimurium to inhibit T cell responses and mediate virulence, and provide new insights into the prerequisites of T cell activation. We propose a model in which Asn deprivation inhibits T cell exit from quiescence by causing suppression of activation-induced metabolic reprogramming.
Following initial TCR engagement in the context of proper costimulation, naïve T cells, which are relatively quiescent, become activated and undergo a growth phase, followed by clonal expansion and functional differentiation, to give rise to effector T cells that can support immunity. This process is energetically demanding and requires enormous quantities of biosynthetic precursors. To access these precursors, the T cells must express appropriate transporters and enzymes in metabolic pathways that permit precursor use. Thus, metabolism plays a crucial role in T cell fate decisions [47, 53, 54] .
Naïve T cells primarily use catabolic metabolism but markedly up-regulate anabolic metabolism following TCR engagement. This metabolic shift increases the ability of the T cells to access biosynthetic precursors and thus may alleviate the metabolic stress associated with T cell activation [48, 55] .
Adaptation to metabolic stress has been linked to mTOR [36] . Our results indicating that mTOR signaling is up-regulated in naïve T cells following TCR engagement (Fig. 4A and B and Supplemental Fig. 3A and B) are consistent with recent evidence indicating that T cell exit from quiescence is dependent on Raptor-mTORC1-mediated metabolic reprogramming [56] . Furthermore, our results indicating that Asn deprivation causes suppression of activation-induced mTOR signaling ( Fig. 4A and B and Supplemental Fig. 3A and B) are consistent with the notion that nutrient starvation causes inhibition of RaptormTORC1 [36] . Thus, Asn is a nutrient important for activationinduced, mTOR-mediated T cell metabolic reprogramming.
Adaptation to metabolic stress also has been linked to autophagy [47, 57] . Our results indicating that autophagy is upregulated from basal levels in naïve T cells following TCR engagement (Fig. 4C and D and Supplemental Fig. 3C and D) are consistent with the notion that T cell activation is a metabolically demanding process [47, 55] . Thus, naïve T cells may use autophagy to meet metabolic needs and up-regulate autophagy to access biosynthetic precursors quickly during the initial phase of activation, when the rapid increase in metabolic demands may outpace the up-regulation of anabolic metabolism.
Metabolic stress, including nutrient stress, causes inhibition of Raptor-mTORC1 and induction of autophagy in the majority of cultured mammalian cells [43, 58] . In contrast to this prevailing paradigm, our results indicate that mTOR signaling and autophagy are up-regulated concurrently in naïve T cells following TCR engagement (Fig. 4A-D and Supplemental Fig. 3A-D ). An immediate implication of these results is that the process of activation-induced autophagy in T cells may be mTOR independent and therefore, fundamentally different from the process of starvation-induced autophagy. Our results indicating that Asn deprivation causes inhibition of activation-induced autophagy (Fig. 4C and D and Supplemental Fig. 3C and D) are consistent with this hypothesis and the notion that the metabolic needs of T cells are very different from those of other cell types [48, 55] . We conclude that activation-induced autophagy in T cells may be a noncanonical, mTOR-independent process that requires exogenous Asn. Whereas future studies will define the role of autophagy in T cell activation, recent evidence has indicated that autophagy is essential for effector T cell survival and memory formation [59] . Thus, autophagy is critical for T cell function at multiple different levels.
Despite recent progress [60] , the basic mechanisms used by T cells to sense nutrient availability and access biosynthetic precursors are not well understood. However, recent evidence has indicated that the oncogenic transcription factor Myc controls activation-induced T cell metabolic reprogramming [50] . This metabolic reprogramming is characterized by increased aerobic glycolysis, which in turn, leads to an increase in L-lactate secretion [50] . Our results indicating that Asn deprivation causes inhibition of T cell activation characterized by the suppression of Myc expression (Fig. 4E and 4F and Supplemental Fig. 3E and F) and L-lactate secretion ( Fig. 4G and H ) lead us to conclude that activation-induced T cell metabolic reprogramming requires exogenous Asn.
Nutrient availability, including amino acid availability, is a key element in an environment supportive of protein synthesis. Our results indicating that exogenous Asn, a nonessential amino acid, is important for naïve T cells to synthesize new proteins following TCR engagement (Figs. 3 and 5) are consistent with the notion that nutrient availability is essential for proper T cell activation [54] . We used an innovative MS-based approach to examine the global impact of exogenous Asn on T cell activation. From the data we obtained, we could trace the incorporation of exogenous Asn into newly synthesized proteins at a large scale and identify proteins differentially affected by the enzymatic activity of Salmonella Typhimurium L-Asnase II. Moreover, we found that Asn deprivation, mediated by L-Asnase II of Salmonella Typhimurium, causes suppression of cellular processes, such as those involved in protein synthesis, metabolism, and immune response ( Fig. 5 and Supplemental Fig. 4) , providing future directions for defining the role of Asn metabolism in T cell activation.
The metabolism of activated T cells is remarkably similar to that of cancer cells, and a number of signaling pathways that drive oncogenesis, including the mTOR metabolic pathway, are also important for T cell activation [47, 54, 55] . The targeting of cell metabolism holds enormous potential for the development of new anti-cancer therapies, and our results described herein suggest that the targeting of cell metabolism may similarly provide new strategies to fight infectious diseases. The L-Asnase II gene is highly conserved in Gram-negative bacteria and has been shown to contribute to the virulence of a number of important human pathogens, including Salmonella Typhimurium [13] , Helicobacter pylori [61] , Campylobacter jejuni [62] , and Mycobacterium tuberculosis [63] .
L-Asnases have been the cornerstone of acute lymphoblastic leukemia treatment since the late 1970s. L-Asnases are used for remission induction and intensification treatment in all pediatric regimens, as well as in the majority of adult treatment protocols, and act through mechanisms that likely involve amino acid starvation of leukemic cells [31, 64] . Our findings indicate that pathogens competing with the host for nutrients may similarly use Asn deprivation to limit T cell responses.
